AME Cloud Ventures — 2025 Investments
5 investments dated 2025 · listed companies and verified rows first · show all
HealthtechWaltham, US
Adam Sachs(President)Sammy Khalifa(Chief Technology Officer)Stephen From(Chief Executive Officer)Sarah Romano(Chief Financial Officer)
BoardJoseph Doherty(Director)David Ho(Director)
Co-investorsInnovation EndeavorsKhosla Ventures
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical DevicesSouth San Francisco, US
Max Mumbach(Founding Scientist, Target Discovery)Jeffrey Verboon(Founding Scientist, Computational Biology)Ansu Satpathy(Founder)Kevin Parker, PhD(Chief Executive Officer, Board Director; co-founder)Ansuman Satpathy, MD, PhD(Co-founder; Board Director)Howard Chang(Co-founder)
Co-investors8VCAndreessen HorowitzArtis VenturesGlobal BioAccess FundHAWKTAILPfizer Venture Investments+6 more
Flint connects international and U.S.-based healthcare professionals with hospitals and care organizations offering direct employment and pathways to permanent residency, addressing the critical shortage of nurses in the United States.
HealthtechHR TechVancouver, CA
Kenton Jarvie(Founder)inAnson Kung(Founder)in
Co-investorsY CombinatorAudaciousHaystackMPG FundAfore CapitalBasis Set Ventures+1 more
Flint is an AI-powered platform providing personalized learning tools for K-12 schools, offering student analytics, instant feedback, and AI tutoring across multiple subjects.
AI & Machine LearningEdTechNew York City, US
Sohan Choudhury(Founder)inJinseo Park(Founder)in
Co-investorsAfore CapitalBasis Set VenturesY CombinatorPatron
Hepta develops LiquidTransformer, an AI platform for analyzing cell-free DNA fragments in blood to detect chronic disease molecular signals.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Hamed Amini(Founder)inSoheil Damangir(Founder)
Co-investorsIllumina VenturesAlumni VenturesFelicis VenturesSeaX Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.